Arbutus Biopharma Corporation (ABUS) NASDAQ
4.26
-0.22(-4.91%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.26
-0.22(-4.91%)
Currency In USD
| Market Cap | 921.59M |
| Enterprise Value | 907.77M |
| P/E Ratio | 5.14 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 4.4 |
| Price/Book Ratio | 3.17 |
| Enterprise/Revenue | 4.28 |
| Enterprise/EBITDA | 5.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.84 |
| Operating Margin | 0.81 |
| Return On Assets | 0.58 |
| Return On Equity | 1.29 |
| Revenue | 14.08M |
| Revenue/Share | 0.99 |
| Gross Profit | 13.72M |
| EBITDA | -26.69M |
| Net Income | -33.5M |
| Diluted EPS | -0.17 |
| Total Cash | 95.23M |
| Total Cash/Share | 0.49 |
| Total Debt | 631,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 54.26 |
| Book Value Per Share | 1.34 |
| 52-Week Change | 26.79 |
| 52-Week High | 5.1 |
| 52-Week Low | 3.04 |
| Moving Average 50 Days | 4.39 |
| Moving Average 200 Days | 4.36 |
| Average Volume | 2.19M |
| Shares Outstanding | 197.54M |
| % Held by Institutions | 72.54 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | November 04, 2010 |